Tulbah AS. Formulation and in vitro characterization of inhalable dasatinib-nanoemulsion as a treatment potential against A549 and Calu-3 lung cancer cells. IJHS [Internet]. 2025 Jan. 1 [cited 2025 Jan. 12];19(1):4-14. Available from: https://pub.qu.edu.sa/index.php/journal/article/view/8643